Carl Dambkowski - Dec 18, 2023 Form 4 Insider Report for Apogee Therapeutics, Inc. (APGE)

Role
Chief Medical Officer
Signature
/s/ Matthew Batters, as attorney-in-fact for Carl Dambkowski
Stock symbol
APGE
Transactions as of
Dec 18, 2023
Transactions value $
$0
Form type
4
Date filed
12/20/2023, 08:01 PM
Previous filing
Jul 17, 2023
Next filing
Jul 5, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APGE Stock Option (Right to Buy) Award $0 +175K $0.00 175K Dec 18, 2023 Common Stock 175K $22.86 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option represents the right to purchase 175,345 shares of the Issuer's common stock, which will vest in forty-eight equal monthly installments over a four-year period from the date of grant, subject to the Reporting Person's continued service to the Issuer.

Remarks:

Exhibit 24 - Power of Attorney